Oncternal begins phase 1b trial of breast cancer drug cirmtuzumab and paclitaxel combo
September 13, 2018 No Comment
US oncology company Oncternal Therapeutics said that the first patient enrolled in a phase 1b trial of its investigational breast cancer drug cirmtuzumab in combination with paclitaxel, a standard-of-care chemotherapy drug, has been dosed. The phase 1b trial is evaluating the anti-ROR1 monoclonal antibody cirmtuzumab combination with paclitaxel, in breast cancer patients who are negative […]
Continue reading …
An all new smart bra dubbed as EVA Smart Bra has been developed by a Mexican teenager that can potentially be a life saver for many women suffering from early stages of breast cancer. Julian Rios Cantu, all of just 18 years of age, and the co-founder and CEO of Higia Technologies, has developed the […]
Continue reading …
Did you ever wonder whether sleeping with your bra on can create problems for you? Then, you are right, experts are advising to take off bra before sleeping in the night as it has the potential to cause many health issues which we will be revealing the Five Reasons Why You Should Take Off Your Bra Before […]
Continue reading …Cannabis oil benefits breast cancer | Cannabis oil for cancer treatment in India
April 21, 2018 No Comment
As per the latest research reports, it was found that cannabis oil compounds are capable of killing malignant cells of cancer. Cannabis is used as a food supplement in the Western countries and is sold legally. Cannabis oil for breast cancer treatment Cannabis oil was used by a 69 year old woman for the treatment […]
Continue reading …
Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival (PFS) in a phase 3 breast cancer trial. The combination of Lilly breast cancer drug abemaciclib with fulvestrant was proved to be more effective than the fulvestrant plus placebo combination […]
Continue reading …
Roche breast cancer drug, Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy has been demonstrated in a phase 3 trial to have cut the risk of disease recurrence besides increasing the life span of patients with an aggressive form of early breast cancer. Roche Breast Cancer Trial APHINITY Results The breast cancer drug combination which met […]
Continue reading …Breast Cancer Cognitive Impairment : Belgium University to conduct ground-breaking clinical trial
October 22, 2016 No Comment
Belgium-based The University of Antwerp is all set to conduct its first clinical trial to reduce the severity of the cognitive deficit associated with breast cancer treatment. For this, the University of Antwerp will be using a video game training and assessment, scientifically-designed by UK-based My Cognition which focuses on cognitive health. Breast Cancer Cognitive […]
Continue reading …Genetic Breast Cancer : Causes, Symptoms and Treatment with New Drug Therapy
February 4, 2013 Comments Off on Genetic Breast Cancer : Causes, Symptoms and Treatment with New Drug Therapy
What is meant by Breast Cancer? Who gets Breast Cancer Mostly? Breast cancer is a cancerous growth deep in the breast tissue. It is most common in women. Less frequently it is also seen in about 1% of cancers occurring in men. Breast cancer is the major cause of death of cancer in women. Because […]
Continue reading …
Business News Today
- TASI acquires German inspection systems manufacturer Cassel Messtechnik
- ALX Oncology raises $105m to advance clinical development of ALX148
- ImmunogenX enrolls patients for Solutions for Celiac trial of Latiglutenase
- McDermott wins contract for six crude oil storage tanks in Texas
- Badin IV South Block, Pakistan : Petroleum Exploration, Jura Energy begin commercial production
- Google wraps up $2.6bn acquisition of data platform company Looker
- ABG buys majority stake in spirits distribution company Indie Brands
- Arthur J. Gallagher acquires Illinois-based Affiliated Benefit Consultants
- Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer
- Antios Therapeutics begins phase 1 trial for ATI-2173, a chronic hepatitis B candidate
